762648

526783

DRAGARWQ

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

Dr Agarwal S Eye Hosp L Share Price Today

DR. AGARWAL'S EYE HOSP L made its stock market debut on 20 April 2026 and is currently trading at ₹5034, up by ₹34.89 from the previous close. The stock touched an intraday high of ₹5075.00 and a low of ₹4990.00 during the latest trading session.

Dr Agarwal S Eye Hosp L performance

Today’s low Today’s high
₹ 4990.00 ₹ 5075.00
₹ 5068.00
52 week low 52 week high
₹ 4600.00 ₹ 6059.70
₹ 5068.00
Open Price ₹ 5072.00
Prev. Close ₹ 4999.10
Volume (Shares) 346.00
Total traded value ₹ 17.53
Upper Circuit ₹ 5998.90
Lower Circuit ₹ 3999.30
info

Investment Returns

Over 1 Month -2.11% Over 3 Months 4.41% Over 6 Months 0.00% Over 1 Year 0.00%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

Dr Agarwal S Eye Hosp L fundamentals


  • Market cap (Cr) 2,449.30
  • P/E Ratio (TTM) 34.50
  • Beta 0.07
  • Book Value / share 716.56
  • Return on equity 29.80%
  • EPS (TTM) 145.05
  • Dividend yield 0.08%
  • Net profit/quarter (Cr) 16.24
info icon alternate text
  • Market cap (Cr) 2,436.00
  • P/E Ratio (TTM) 34.50
  • Beta 0.32
  • Book Value / share 716.56
  • Return on equity 29.80%
  • EPS (TTM) 145.05
  • Dividend yield 0.08%
  • Net profit/quarter (Cr) 16.24
info icon alternate text

Dr Agarwal S Eye Hosp L Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2026 (Values in Cr)
Revenue 120.01
Operating Expense 100.33
Net Profit 16.24
Net Profit Margin (%) 13.53
Earnings Per Share (EPS) 33.60
EBITDA 35.30
Effective Tax Rate (%) 23.57
Particulars DEC 2025 (Values in Cr)
Revenue 116.22
Operating Expense 95.54
Net Profit 17.28
Net Profit Margin (%) 14.86
Earnings Per Share (EPS) 35.76
EBITDA 37.14
Effective Tax Rate (%) 26.31
Particulars SEP 2025 (Values in Cr)
Revenue 117.72
Operating Expense 92.68
Net Profit 19.32
Net Profit Margin (%) 16.41
Earnings Per Share (EPS) 41.04
EBITDA 40.76
Effective Tax Rate (%) 24.88
Particulars JUN 2025 (Values in Cr)
Revenue 116.92
Operating Expense 94.53
Net Profit 17.26
Net Profit Margin (%) 14.76
Earnings Per Share (EPS) 36.72
EBITDA 37.93
Effective Tax Rate (%) 25.57
Particulars MAR 2025 (Values in Cr)
Revenue 99.83
Operating Expense 81.33
Net Profit 15.99
Net Profit Margin (%) 16.01
Earnings Per Share (EPS) 34.02
EBITDA 31.69
Effective Tax Rate (%) 14.03
Particulars MAR 2026 (Values in Cr)
Revenue 470.87
Operating Expense 383.08
Net Profit 70.10
Net Profit Margin (%) 14.88
Earnings Per Share (EPS) 147.02
EBITDA 151.13
Effective Tax Rate (%) 25.11
Particulars MAR 2025 (Values in Cr)
Revenue 397.15
Operating Expense 331.54
Net Profit 54.65
Net Profit Margin (%) 13.76
Earnings Per Share (EPS) 116.28
EBITDA 123.59
Effective Tax Rate (%) 22.70
Particulars MAR 2024 (Values in Cr)
Revenue 319.30
Operating Expense 262.02
Net Profit 46.36
Net Profit Margin (%) 14.51
Earnings Per Share (EPS) 98.64
EBITDA 96.03
Effective Tax Rate (%) 25.52
Particulars MAR 2023 (Values in Cr)
Revenue 268.10
Operating Expense 220.25
Net Profit 36.92
Net Profit Margin (%) 13.77
Earnings Per Share (EPS) 78.55
EBITDA 76.44
Effective Tax Rate (%) 25.26
Particulars MAR 2022 (Values in Cr)
Revenue 201.21
Operating Expense 170.16
Net Profit 24.10
Net Profit Margin (%) 11.97
Earnings Per Share (EPS) 51.29
EBITDA 58.93
Effective Tax Rate (%) 25.41
Particulars MAR 2025 (Values in Cr)
Book Value / Share 445.98
ROE % 29.80
ROCE % 17.30
Total Debt to Total Equity 1.64
EBITDA Margin 31.47
Particulars MAR 2024 (Values in Cr)
Book Value / Share 334.36
ROE % 34.28
ROCE % 17.89
Total Debt to Total Equity 1.85
EBITDA Margin 30.43
Particulars MAR 2023 (Values in Cr)
Book Value / Share 241.15
ROE % 38.56
ROCE % 18.22
Total Debt to Total Equity 2.22
EBITDA Margin 28.95
Particulars MAR 2022 (Values in Cr)
Book Value / Share 166.32
ROE % 36.29
ROCE % 19.63
Total Debt to Total Equity 1.96
EBITDA Margin 29.77
Particulars MAR 2021 (Values in Cr)
Book Value / Share 116.30
ROE % -2.60
ROCE % 10.36
Total Debt to Total Equity 1.15
EBITDA Margin 22.74
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 12.17
Total Assets 613.32
Total Liabilities 613.32
Total Equity 209.61
Share Outstanding 0
Price to Book Ratio 9.09
Return on Assets (%) 8.91
Return on Capital (%) 17.86
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 33.74
Total Assets 495.76
Total Liabilities 495.76
Total Equity 157.15
Share Outstanding 0
Price to Book Ratio 9.28
Return on Assets (%) 9.35
Return on Capital (%) 22.24
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 28.10
Total Assets 389.94
Total Liabilities 389.94
Total Equity 113.34
Share Outstanding 0
Price to Book Ratio 3.80
Return on Assets (%) 9.46
Return on Capital (%) 23.49
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 28.80
Total Assets 314.01
Total Liabilities 314.01
Total Equity 78.17
Share Outstanding 0
Price to Book Ratio 4.39
Return on Assets (%) 7.67
Return on Capital (%) 21.89
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 22.19
Total Assets 155.23
Total Liabilities 155.23
Total Equity 54.66
Share Outstanding 0
Price to Book Ratio 2.69
Return on Assets (%) -0.92
Return on Capital (%) -1.89
Particulars MAR 2025 (Values in Cr)
Net Income 70.70
Cash from Operations 114.61
Cash from Investing -132.78
Cash from Financing 16.58
Net change in Cash -21.72
Free Cash Flow 217.47
Particulars MAR 2024 (Values in Cr)
Net Income 62.25
Cash from Operations 103.38
Cash from Investing -70.04
Cash from Financing -14.23
Net change in Cash 5.50
Free Cash Flow 174.70
Particulars MAR 2023 (Values in Cr)
Net Income 49.40
Cash from Operations 81.14
Cash from Investing -70.61
Cash from Financing 0.26
Net change in Cash -0.73
Free Cash Flow 151.48
Particulars MAR 2022 (Values in Cr)
Net Income 24.10
Cash from Operations 65.61
Cash from Investing -46.28
Cash from Financing -3.81
Net change in Cash 6.59
Free Cash Flow 112.34
Particulars MAR 2021 (Values in Cr)
Net Income -1.43
Cash from Operations 37.19
Cash from Investing -10.96
Cash from Financing -7.59
Net change in Cash 15.30
Free Cash Flow 48.38
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
APOLLO HOSPITALS ENTERPRISE LT 8496.80 62.45 12.89 122170.95 6680.00 8624.20
FORTIS MALAR HOSPITALS LIMITED 52.22 23.63 2.85 97.87 40.75 76.00
SHREE PACETRONIX LTD. 134.30 16.03 2.82 50.36 66.10 283.15
TRANSGENE BIOTEK LTD. 3.16 0.00 2.85 23.94 1.83 5.26
VIMTA LABS LIMITED 478.55 35.16 6.23 2137.65 377.30 902.85
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
APOLLO HOSPITALS ENTERPRISE LT 8496.80 81.38 12.26 122170.95 6680.00 8624.20
[-] 0.0 0.0 0.0 0.0 0.0 0.0
CHENNAI MEENAKSHI MULTISPECIAL 39.25 0.00 -9.55 29.32 30.30 57.48
KOVAI MEDICAL CENTER & HO 5834.80 26.11 4.83 6383.27 5010.00 6725.00

Dr Agarwal S Eye Hosp L shareholding pattern

Holding
23.0%
72.66%
2.2%
2.12%
29.26%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

Dr Agarwal S Eye Hosp L Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
5068.00 1.37 redarrow
red-green-graph indicator
0 Bearish
16 Bullish
  • 5 Days 4990.70
  • 26 Days 5011.20
  • 10 Days 4994.30
  • 50 Days 5025.70
  • 12 Days 4998.20
  • 100 Days 5025.70
  • 20 Days 5009.00
  • 200 Days 5025.70
5000.70 PIVOT
First Support 4911.50 First Resistance 5088.30 Second Support 4823.90 Second Resistance 5177.50 Third Support 4734.70 Third Resistance 5265.10
RSI 50.34 ADX 36.10 MACD -12.96 Williams % R -60.78 Commodity Channel Index (CCI) -29.45
Date 2026-06-19 Week 526.00 Same Day 1284.00 Month 533.00
1 Year 0.07 3 Year 0.07
Over 1 Month
-2.11% down
Over 1 Year
0.00% down
Over 3 Months
4.41% down
Over 3 Years
0.00% down
Over 6 Months
0.00% down
Over 5 Years
0.00% down

Dr Agarwal S Eye Hosp L Corporate Actions

Dividend date Dividend amount Dividend type Record date Instrument type
07 Nov 2025 3.0 Interim 07 Nov 2025 Equity shares
18 Sep 2025 3.5 Final 18 Sep 2025 Equity shares
08 Nov 2024 2.5 Interim 08 Nov 2024 Equity shares
19 Aug 2024 2.5 Final 20 Aug 2024 Equity shares
31 Oct 2023 2.5 Interim 31 Oct 2023 Equity shares
14 Sep 2023 3.0 Final 15 Sep 2023 Equity shares
06 Sep 2022 3.0 Final 08 Sep 2022 Equity shares
16 Sep 2019 1.5 Final 18 Sep 2019 Equity shares
21 Aug 2018 1.2 Final 24 Aug 2018 Equity shares
14 Aug 2017 1.5 Final 17 Aug 2017 Equity shares
12 Aug 2016 0.8 Final 17 Aug 2016 Equity shares
01 Sep 2015 1.2 Final 03 Sep 2015 Equity shares
28 Aug 2014 1.2 Final 02 Sep 2014 Equity shares
02 Aug 2013 1.2 Final 06 Aug 2013 Equity shares
11 Aug 2011 1.2 Final 16 Aug 2011 Equity shares
13 Aug 2010 0.8 Final 17 Aug 2010 Equity shares
13 Sep 2007 1.5 Final 15 Sep 2007 Equity shares
12 Sep 2005 0.0 Final 14 Sep 2005 Equity shares
Dividend date Dividend amount Dividend type Record date Instrument type
07 Nov 2025 3.0 Interim 07 Nov 2025 Equity shares
18 Sep 2025 3.5 Final 18 Sep 2025 Equity shares
08 Nov 2024 2.5 Interim 08 Nov 2024 Equity shares
19 Aug 2024 2.5 Final 20 Aug 2024 Equity shares
31 Oct 2023 2.5 Interim 31 Oct 2023 Equity shares
14 Sep 2023 3.0 Final 15 Sep 2023 Equity shares
06 Sep 2022 3.0 Final 08 Sep 2022 Equity shares
16 Sep 2019 1.5 Final 18 Sep 2019 Equity shares
21 Aug 2018 1.2 Final 24 Aug 2018 Equity shares
14 Aug 2017 1.5 Final 17 Aug 2017 Equity shares
12 Aug 2016 0.8 Final 17 Aug 2016 Equity shares
01 Sep 2015 1.2 Final 03 Sep 2015 Equity shares
28 Aug 2014 1.2 Final 02 Sep 2014 Equity shares
02 Aug 2013 1.2 Final 06 Aug 2013 Equity shares
11 Aug 2011 1.2 Final 16 Aug 2011 Equity shares
13 Aug 2010 0.8 Final 17 Aug 2010 Equity shares
13 Sep 2007 1.5 Final 15 Sep 2007 Equity shares
12 Sep 2005 0.0 Final 14 Sep 2005 Equity shares

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Dr Agarwals Eye Hospital Ltd?

Answer Field

Dr Agarwals Eye Hospital Ltd share price is for NSE ₹ 5,034.00 & for BSE ₹ 5,045.30 as on Jun 22 2026 03:30 PM.

What is the Market Cap of Dr Agarwals Eye Hospital Ltd Share?

Answer Field

The market cap of Dr Agarwals Eye Hospital Ltd for NSE ₹ 2,449.30 & for BSE ₹ 0.00 as on Jun 22 2026 03:30 PM.

What is the 52 Week High and Low of Dr Agarwals Eye Hospital Ltd?

Answer Field

The 52 Week High and Low of Dr Agarwals Eye Hospital Ltd for NSE is ₹ 6,059.70 and ₹ 4,600.00 and for BSE is ₹ 6,392.00 and ₹ 4,142.00.

What is 1 year return for Dr Agarwals Eye Hospital Ltd?

Answer Field

The 1 year returns on the stock has been 0.00%.

What is the P/E Ratio of Dr Agarwals Eye Hospital Ltd Share?

Answer Field

As on Jun 22 2026 03:30 PM the price-to-earnings (PE) ratio for Dr Agarwals Eye Hospital Ltd share is 34.50.

What is the PB ratio of Dr Agarwals Eye Hospital Ltd Share?

Answer Field

As on Jun 22 2026 03:30 PM, the price-to-book (PB) ratio for Dr Agarwals Eye Hospital Ltd share is 716.56.

How to Buy Dr Agarwals Eye Hospital Ltd Share?

Answer Field

You can trade in Dr Agarwals Eye Hospital Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Dr Agarwals Eye Hospital Ltd Share on Bajaj Broking App?

Answer Field

To buy Dr Agarwals Eye Hospital Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Dr Agarwals Eye Hospital Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image
Get Free Demat Account*
+91
close-img
Authorise with OTP
Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|